New mutation linked to ovarian cancer can be passed down through dad

February 15, 2018, Public Library of Science
Fig 1. X-linked model. Schema for X-linked inheritance when cancer status is specific to women (all carrier men are effectively disease censored). Two family patterns with a pair of first-degree affected women are the maternal grandmother (MGM) family and the paternal grandmother (PGM) family. Stratton's paradox implies that PGM families are more likely under X-linkage because a father must pass the variant to all of his daughters. The rates are equal if the variant is autosomal. Credit: Kevin H. Eng and colleagues

A newly identified mutation, passed down through the X-chromosome, is linked to earlier onset of ovarian cancer in women and prostate cancer in father and sons. Kunle Odunsi, Kevin H. Eng and colleagues at Roswell Park Comprehensive Cancer Center in Buffalo, New York, report these findings February 15th, 2018, in PLOS Genetics.

In earlier studies, researchers noticed that when a woman develops ovarian , her sister faces a higher risk of also developing the disease than her mother, an observation they found difficult to explain. This observation led Eng and colleagues to investigate whether on the X-chromosome, potentially passed down through the father, may contribute to his daughters' risk of ovarian cancer.

Using the Familial Ovarian Cancer Registry, a donor-funded resource based at Roswell Park, the researchers collected information about pairs of granddaughters and grandmothers and sequenced portions of the X-chromosome from 186 women affected by the cancer. They found that cases of ovarian cancer linked to genes inherited from the paternal grandmother had an earlier age-of-onset than cases linked to , and were also associated with higher rates of in fathers and sons. Additional sequencing led the researchers to identify a previously unknown mutation on the X-chromosome that may be associated with cases of ovarian cancer that develop more than 6 years earlier that average.

The study proposes that a gene on the X-chromosome may contribute to a woman's risk of developing ovarian cancer, independently of other known , such as the BRCA genes. Future studies will be needed, however, to confirm the identity and function of this gene. This observation suggests that there may be many cases of seemingly sporadic ovarian cancer that are actually inherited, and may lead to improved cancer screening and better genetic risk assessment.

"Our study may explain why we find families with multiple affected daughters: because a dad's chromosomes determine the sex of his children, all of his daughters have to carry the same X-chromosome genes," says Eng, an assistant professor of oncology in Roswell Park's Department of Biostatistics and Bioinformatics. What we have to do next is make sure we have the right gene by sequencing more families. This finding has sparked a lot of discussion within our group about how to find these X-linked families. It's an all-or-none kind of pattern: A family with three daughters who all have is more likely to be driven by inherited X mutations than by BRCA mutations."

Explore further: USPSTF recommends against ovarian cancer screening

More information: Eng KH, Szender JB, Etter JL, Kaur J, Poblete S, Huang R-Y, et al. (2018) Paternal lineage early onset hereditary ovarian cancers: A Familial Ovarian Cancer Registry study. PLoS Genet 14(2): e1007194. doi.org/10.1371/journal.pgen.1007194

Related Stories

USPSTF recommends against ovarian cancer screening

February 13, 2018
(HealthDay)—The U.S. Preventive Services Task Force (USPSTF) recommends against screening for ovarian cancer in asymptomatic women. These findings form the basis of a final recommendation statement published in the Feb. ...

Research test identifies BRCA2 gene mutations that lead to breast, ovarian cancers

January 25, 2018
A new test developed by researchers at Mayo Clinic shows which mutations in the BRCA2 gene make women susceptible to developing breast or ovarian cancers. The research behind the test was published today in the American Journal ...

New ovarian cancer drug licensed for use

December 21, 2017
A new drug to delay the spread of ovarian cancer, which was developed from UCL research, has been licensed for use in the UK.

Gene inheritance patterns influence age of diagnosis in BRCA families

December 12, 2011
Women who inherit the cancer genes BRCA1 or BRCA2 from their paternal lineage may get a diagnosis a decade earlier than those women who carry the cancer genes from their mother and her ancestors, according to a new study ...

Research uncovers more inherited genetic mutations linked to ovarian cancer

February 10, 2016
Previous research has established a link between genetic mutations in the BRCA1 and BRCA2 genes to an increased risk of developing ovarian, fallopian tube or peritoneal cancer in women. A recent publication documents the ...

Women's wellness: Early diagnosis for ovarian cancer

September 21, 2016
According to the Centers for Disease Control and Prevention, more than 20,000 women in the U.S. are diagnosed with ovarian cancer each year. September is Ovarian Cancer Awareness month and physicians want to raise awareness ...

Recommended for you

Scientists learn more about how gene linked to autism affects brain

June 18, 2018
New preclinical research shows a gene already linked to a subset of people with autism spectrum disorder is critical to healthy neuronal connections in the developing brain, and its loss can harm those connections to help ...

Targeting the engine room of the cancer cell

June 18, 2018
Researchers at Columbia University Irving Medical Center (CUIMC) have developed a highly innovative computational framework that can support personalized cancer treatment by matching individual tumors with the drugs or drug ...

161 genetic factors for myopia identified

June 15, 2018
The international Consortium for Refractive Error and Myopia (CREAM) recently published the largest-ever genetic study of myopia in Nature Genetics. Researchers from the Gutenberg Health Study at the Medical Center of Johannes ...

Genetic disorder identified in children

June 15, 2018
A genetic defect affecting normal development in children has been identified by a study involving University of Queensland researcher and alumnus Professor David Coman.

Scientists discover biomarker for flu susceptibility

June 13, 2018
Researchers at the Stanford University School of Medicine have found a way to predict whether someone exposed to the flu virus is likely to become ill.

Brain secrets that flow in our blood

June 13, 2018
Our blood can be used to uncover genetic secrets inside the brain, according to University of Queensland research.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.